Front Barnett Associates’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $43.4M | Sell |
85,753
-2,241
| -3% | -$1.19M | 5.21% | 3 |
|
|
2023
Q2 | $45.9M | Sell |
87,994
-5,639
| -6% | -$3.04M | 5.18% | 2 |
|
|
2023
Q1 | $54M | Sell |
93,633
-1,590
| -2% | -$896K | 6.35% | 2 |
|
|
2022
Q4 | $52.4M | Sell |
95,223
-817
| -0.9% | -$433K | 6.62% | 2 |
|
|
2022
Q3 | $48.7M | Sell |
96,040
-490
| -0.5% | -$274K | 6.42% | 2 |
|
|
2022
Q2 | $52.4M | Sell |
96,530
-10,262
| -10% | -$5.65M | 6.38% | 2 |
|
|
2022
Q1 | $63.1M | Sell |
106,792
-6,034
| -5% | -$3.47M | 6.35% | 2 |
|
|
2021
Q4 | $75.3M | Sell |
112,826
-5,777
| -5% | -$3.61M | 7.05% | 2 |
|
|
2021
Q3 | $67.8M | Sell |
118,603
-3,593
| -3% | -$1.97M | 6.95% | 2 |
|
|
2021
Q2 | $61.6M | Sell |
122,196
-17
| -0% | -$8.02K | 6.28% | 2 |
|
|
2021
Q1 | $55.8M | Sell |
122,213
-640
| -0.5% | -$305K | 6.2% | 2 |
|
|
2020
Q4 | $57.2M | Sell |
122,853
-1,531
| -1% | -$718K | 6.79% | 2 |
|
|
2020
Q3 | $54.9M | Sell |
124,384
-1,333
| -1% | -$551K | 7.49% | 2 |
|
|
2020
Q2 | $45.6M | Sell |
125,717
-1,227
| -1% | -$411K | 7.04% | 2 |
|
|
2020
Q1 | $36M | Buy |
126,944
+231
| +0.2% | +$72.8K | 6.88% | 2 |
|
|
2019
Q4 | $41.2M | Sell |
126,713
-461
| -0.4% | -$140K | 6.16% | 2 |
|
|
2019
Q3 | $37M | Sell |
127,174
-653
| -0.5% | -$187K | 6.13% | 2 |
|
|
2019
Q2 | $37.5M | Sell |
127,827
-14,101
| -10% | -$3.88M | 6.3% | 2 |
|
|
2019
Q1 | $38.8M | Sell |
141,928
-1,578
| -1% | -$393K | 6.26% | 2 |
|
|
2018
Q4 | $32.1M | Sell |
143,506
-2,441
| -2% | -$573K | 5.86% | 2 |
|
|
2018
Q3 | $35.6M | Buy |
145,947
+254
| +0.2% | +$58.4K | 5.36% | 2 |
|
|
2018
Q2 | $30.2M | Sell |
145,693
-1,404
| -1% | -$298K | 4.99% | 2 |
|
|
2018
Q1 | $30.4M | Sell |
147,097
-787
| -0.5% | -$165K | 5.09% | 2 |
|
|
2017
Q4 | $28.1M | Sell |
147,884
-2,986
| -2% | -$572K | 4.66% | 2 |
|
|
2017
Q3 | $28.5M | Sell |
150,870
-894
| -0.6% | -$162K | 5.02% | 2 |
|
|
2017
Q2 | $26.5M | Sell |
151,764
-445
| -0.3% | -$74.7K | 4.83% | 2 |
|
|
2017
Q1 | $23.4M | Sell |
152,209
-6,496
| -4% | -$993K | 4.35% | 2 |
|
|
2016
Q4 | $22.4M | Sell |
158,705
-4,504
| -3% | -$664K | 4.32% | 3 |
|
|
2016
Q3 | $26M | Sell |
163,209
-1,618
| -1% | -$249K | 4.96% | 2 |
|
|
2016
Q2 | $24.4M | Sell |
164,827
-2,447
| -1% | -$361K | 4.94% | 2 |
|
|
2016
Q1 | $23.7M | Sell |
167,274
-1,895
| -1% | -$254K | 4.77% | 2 |
|
|
2015
Q4 | $24M | Sell |
169,169
-795
| -0.5% | -$106K | 4.79% | 2 |
|
|
2015
Q3 | $20.8M | Sell |
169,964
-2,185
| -1% | -$285K | 4.31% | 2 |
|
|
2015
Q2 | $22.3M | Sell |
172,149
-940
| -0.5% | -$123K | 4.16% | 2 |
|
|
2015
Q1 | $23.3M | Sell |
173,089
-3,225
| -2% | -$416K | 4.28% | 2 |
|
|
2014
Q4 | $22.1M | Sell |
176,314
-2,744
| -2% | -$334K | 4.19% | 2 |
|
|
2014
Q3 | $21.8M | Sell |
179,058
-3,085
| -2% | -$375K | 4.17% | 2 |
|
|
2014
Q2 | $21.5M | Sell |
182,143
-4,681
| -3% | -$551K | 3.99% | 2 |
|
|
2014
Q1 | $22.5M | Sell |
186,824
-3,160
| -2% | -$376K | 4.35% | 2 |
|
|
2013
Q4 | $21.2M | Sell |
189,984
-2,536
| -1% | -$252K | 4.13% | 2 |
|
|
2013
Q3 | $17.7M | Sell |
192,520
-720
| -0.4% | -$65.1K | 3.79% | 3 |
|
|
2013
Q2 | $16.4M | Buy |
+193,240
| New | +$16.1M | 3.75% | 3 |
|
Other funds holding TMO
Front Barnett Associates's TMO Position: Q3 2023 in Review
Front Barnett Associates reduced its Thermo Fisher Scientific (TMO) stake by 2.5% in Q3 2023, selling an estimated $1.19M and leaving 85,753 shares worth $43.4M. The position accounts for 5.21% of the portfolio, ranked #3.
Front Barnett Associates first reported a position in TMO in Q2 2013 and has held it in 42 quarters since. The position peaked at $75.3M in Q4 2021. 2,365 funds tracked by Wall St. Rank hold TMO as of Q3 2023.
- Front Barnett Associates held 85,753 shares of Thermo Fisher Scientific worth $43.4M as of Q3 2023.
- Front Barnett Associates sold 2,241 Thermo Fisher Scientific shares in Q3 2023, an estimated $1.19M.
- Thermo Fisher Scientific made up 5.21% of Front Barnett Associates's portfolio in Q3 2023, its #3 holding.
- Front Barnett Associates first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 42 quarters since.
- Front Barnett Associates's Thermo Fisher Scientific position peaked at $75.3M in Q4 2021.
- 2,365 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.
Based on Front Barnett Associates's 13F filing for Q3 2023, filed 13 Nov 2023.